LEO Pharma presents new tralokinumab data at EADV 2026 highlighting real-world outcomes and quality of life in adults and adolescents with atopic dermatitis (AD) involving high-burden areas
Businesswire·2026-10-01 16:30
文章核心观点 - LEO Pharma在EADV 2026上展示tralokinumab的新数据 [1] 公司动态 - LEO Pharma发布tralokinumab在EADV 2026上的新数据 [1] - 发布地点为丹麦Ballerup [1] - 发布时间为EADV 2026期间 [1] 行业会议 - EADV 2026为皮肤病学领域重要会议 [1] - tralokinumab为LEO Pharma旗下产品 [1]